CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 53 filers reported holding CASI PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $29,000 | 0.0% | 36,437 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | -32.6% | 36,437 | 0.0% | 0.00% | – |
| Q3 2021 | $43,000 | -23.2% | 36,437 | +0.0% | 0.00% | – |
| Q2 2021 | $56,000 | -87.6% | 36,436 | -80.6% | 0.00% | – |
| Q1 2021 | $451,000 | -18.6% | 187,846 | +0.1% | 0.00% | – |
| Q4 2020 | $554,000 | +106.7% | 187,679 | +6.8% | 0.00% | – |
| Q3 2020 | $268,000 | -38.5% | 175,649 | +0.6% | 0.00% | – |
| Q2 2020 | $436,000 | +27.1% | 174,643 | +4.0% | 0.00% | – |
| Q1 2020 | $343,000 | -30.4% | 167,862 | +5.1% | 0.00% | – |
| Q4 2019 | $493,000 | -9.5% | 159,694 | -2.3% | 0.00% | – |
| Q3 2019 | $545,000 | +1.5% | 163,459 | -2.7% | 0.00% | – |
| Q2 2019 | $537,000 | +9.8% | 167,926 | -1.5% | 0.00% | – |
| Q1 2019 | $489,000 | -29.6% | 170,441 | -1.4% | 0.00% | – |
| Q4 2018 | $695,000 | -2.8% | 172,947 | +12.9% | 0.00% | – |
| Q3 2018 | $715,000 | -36.2% | 153,166 | +12.5% | 0.00% | – |
| Q2 2018 | $1,120,000 | +627.3% | 136,116 | +269.1% | 0.00% | – |
| Q1 2018 | $154,000 | – | 36,880 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 896,137 | $4,185,000 | 2.27% |
| Wellington Shields Capital Management, LLC | 888,333 | $4,149,000 | 0.67% |
| Manatuck Hill Partners, LLC | 15,090 | $70,000 | 0.03% |
| IHT Wealth Management, LLC | 10,725 | $50,000 | 0.01% |
| Perceptive Advisors | 43,682 | $204,000 | 0.01% |
| ALPS ADVISORS INC | 153,234 | $716,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 78,742 | $368,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 5,863 | $28,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,974 | $28,000 | 0.00% |
| METROPOLITAN LIFE INSURANCE CO/NY | 18,585 | $86,792 | 0.00% |